Global Pharmacovigilance Market Report By Type (Service, Software), By Deployment (In-house, Outsource), By End User (Hospitals, Pharmaceutical Companies, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11212767
April 2021
Report Formats:
The global demand for Pharmacovigilance Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
 
Pharmacovigilance is a science related to the detection, collection, assessment, understanding, monitoring, and prevention of adverse effects or any other drug-related problem with the pharmaceutical products. An adverse drug reaction (ADR) is an adverse or harmful reaction of medicines that occurred during its clinical use. The adverse reaction may be of various types including drug toxicity. Pharmacovigilance deals with understanding and identifying the harmful effects of pharmaceutical products and aids in reducing the risk to the patients. Pharmacovigilance is an unavoidable part of drug discovery and development procedures. With the growing consumption of medicines, the need for the proper pharmacovigilance is also accelerated.
 
Market Dynamics
 
The prime forces that are driving the global pharmacovigilance market include growing drug consumption, rapidly advancing drug discovery and development, and rising incidences of adverse drug reactions & drug toxicity. Furthermore, factors such as a growing preference for personalized medicine and a rising trend for outsourcing pharmacovigilance services are expected to foster the global market. The advancement in information systems and ADR databases is also supporting the growth of the pharmacovigilance market. COVID-19 pandemic is anticipated to stimulate the market more energetically, during the forecast period, as the global pharmaceutical manufacturers are working strenuously to discover the drug against the disease. However, supply chain disruption may agitate the global market for some period.
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of pharmacovigilance.
 
Market Segmentation
 
The entire pharmacovigilance market has been sub-categorized into type, deployment and end user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Type
  • Service
  • Software
 
By Deployment
  • In-house
  • Outsource
 
By End User
  • Hospitals
  • Pharmaceutical Companies
  • Others
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for pharmacovigilance market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Global Pharmacovigilance Market Share by Region (Representative Graph)
 
Global Pharmacovigilance Market Share
 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the pharmacovigilance market include Quanticate (U.S), Pharmaceutical Product Development, LLC (U. S), Cognizant (U.S), Parexel International Corporation (U.S), IQVIA (U.S), ICON plc (Ireland), Bioclinica (U.S), Accenture plc (Ireland), Covance Inc. (U.S). This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
                                          
METHODOLOGY:
 
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Pharmacovigilance Market
       2.2. Global Pharmacovigilance Market Snapshot
 
3 . PHARMACOVIGILANCE – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Pharmacovigilance Market
       3.3. Market Restraints of Pharmacovigilance Market
       3.4. Opportunities of Pharmacovigilance Market
       3.5. Trends of Pharmacovigilance Market
       3.6. Porter’s Five Force Analysis of Pharmacovigilance Market
       3.7. Pharmacovigilance Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Type
           3.7.2 Market Attractive Analysis by Deployment
           3.7.3 Market Attractive Analysis by End User
           3.7.4 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Pharmacovigilance Value Chain Analysis
       4.2. Pharmacovigilance Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Pharmacovigilance Raw Material Manufactures List
           4.2.3. Price Trend of Pharmacovigilance Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Pharmacovigilance Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Pharmacovigilance Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Pharmacovigilance Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Pharmacovigilance Market
 
6 . GLOBAL PHARMACOVIGILANCE MARKET ANALYSIS BY TYPE
       6.1 Overview by Type
       6.2 Historical Data 2015-2018
       6.3 Global Pharmacovigilance Market Analysis by Type
       6.4 Market Analysis of Service by Regions
       6.6 Market Analysis of Software by Regions
 
7 . GLOBAL PHARMACOVIGILANCE MARKET ANALYSIS BY DEPLOYMENT
       7.1 Overview by Deployment
       7.2 Historical Data 2015-2018
       7.3 Global Pharmacovigilance Market Analysis by Deployment
       7.4 Market Analysis of In-house by Regions
       7.5 Market Analysis of Outsource by Regions
 
8 . GLOBAL PHARMACOVIGILANCE MARKET ANALYSIS BY END USER
       8.1 Overview by End User
       8.2 Historical Data 2015-2018
       8.3 Global Pharmacovigilance Market Analysis by End User
       8.4 Market Analysis of Hospitals by Regions
       8.5 Market Analysis of Pharmaceutical Companies by Regions
       8.6 Market Analysis of Others by Regions
 
9 . GLOBAL PHARMACOVIGILANCE MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview and Historic Data
           9.3.2. North America Pharmacovigilance Market Estimate By Market Segment
           9.3.3. North America Pharmacovigilance Market Estimate By Country
           9.3.4. United State
           9.3.5. Canada
           9.3.6. Mexico
       9.4. Europe
           9.4.1. Overview and Historic Data
           9.4.2. Europe Pharmacovigilance Market Estimate by Market Segment
           9.4.3. Europe Pharmacovigilance Market Estimate by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7. Italy
           9.4.8. Russia
           9.4.9. Rest Of Europe
       9.5. Asia Pacific
           9.5.1. Overview and Historic Data
           9.5.2. Asia Pacific Pharmacovigilance Market Estimate by Market Segment
           9.5.3. Asia Pacific Pharmacovigilance Market Estimate by Country
           9.5.4. China
           9.5.5. India
           9.5.6. Japan
           9.5.7. South Korea
           9.5.8. Australia
           9.5.9. Rest Of Asia Pacific
       9.6. Latin America
           9.6.1. Overview and Historic Data
           9.6.2. Latin America Pharmacovigilance Market Estimate by Market Segment
           9.6.3. Latin America Pharmacovigilance Market Estimate by Country
           9.6.4. Brazil
           9.6.5. Argentina
           9.6.6. Peru
           9.6.7. Chile
           9.6.8. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview and Historic Data
           9.7.2. Middle East & Africa Pharmacovigilance Market Estimate by Market Segment
           9.7.3. Middle East & Africa Pharmacovigilance Market Estimate by Country
           9.7.4. Saudi Arabia
           9.7.5. UAE
           9.7.6. Israel
           9.7.7. South Africa
           9.7.8. Rest Of Middle East And Africa
 
10 . COMPETITIVE LANDSCAPE OF THE PHARMACOVIGILANCE COMPANIES
       10.1. Pharmacovigilance Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments
 
11 . COMPANY PROFILES OF PHARMACOVIGILANCE INDUSTRY
       11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. Quanticate (U.S)
           11.3.1. Company Overview
           11.3.2. Financials
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. Pharmaceutical Product Development, LLC (U. S)
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. Cognizant (U.S)
           11.5.1. Company Overview
           11.5.2. Financials
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. Parexel International Corporation (U.S)
           11.6.1. Company Overview
           11.6.2. Financials
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. IQVIA (U.S)
           11.7.1. Company Overview
           11.7.2. Financials
           11.7.3. Products
           11.7.4. Recent Developments
       11.8. ICON plc (Ireland)
           11.8.1. Company Overview
           11.8.2. Financials
           11.8.3. Products
           11.8.4. Recent Developments
       11.9. Bioclinica (U.S)
           11.9.1. Company Overview
           11.9.2. Financials
           11.9.3. Products
           11.9.4. Recent Developments
       11.10. Accenture plc (Ireland)
           11.10.1. Company Overview
           11.10.2. Financials
           11.10.3. Products
           11.10.4. Recent Developments
       11.11. Covance Inc. (U.S)
           11.11.1. Company Overview
           11.11.2. Financials
           11.11.3. Products
           11.11.4. Recent Developments
 
 *Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Pharmacovigilance Market Snapshot
  • Drivers of The Global Pharmacovigilance Market Impact Analysis
  • Restraints of The Global Pharmacovigilance Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pharmacovigilance Market: Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Pharmacovigilance Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on Pharmacovigilance Market
  • Global Pharmacovigilance Market Analysis by Type (USD MN)
  • Historic Data 2015-2018
  • Global Pharmacovigilance Market Analysis in Service by Geography (USD MN)
  • Global Pharmacovigilance Market Analysis in Software by Geography (USD MN)
  • Global Pharmacovigilance Market Analysis by Deployment (USD MN)
  • Historic Data 2015-2018
  • Global Pharmacovigilance Market Analysis in In-house by Geography (USD MN)
  • Global Pharmacovigilance Market Analysis in Outsource by Geography (USD MN)
  • Global Pharmacovigilance Market Analysis by End User (USD MN)
  • Historic Data 2015-2018
  • Global Pharmacovigilance Market Analysis in Hospitals by Geography (USD MN)
  • Global Pharmacovigilance Market Analysis in Pharmaceutical Companies by Geography (USD MN)
  • Global Pharmacovigilance Market Analysis in Others by Geography (USD MN)
  • Historic Data 2015-2018
  • Global Pharmacovigilance Market by Geography (USD MN)
  • Historic Data 2015-2018
  • North America Pharmacovigilance Market Analysis by Type (USD MN)
  • North America Pharmacovigilance Market Estimate by Deployment (USD MN)
  • North America Pharmacovigilance Market Analysis by End User (USD MN)
  • North America Pharmacovigilance Market Estimate by Country (USD MN)
  • United State Pharmacovigilance Market Analysis by Type (USD MN)
  • United State Pharmacovigilance Market Estimate by Deployment (USD MN)
  • United State Pharmacovigilance Market Analysis by End User (USD MN)
  • Canada Pharmacovigilance Market Analysis by Type (USD MN)
  • Canada Pharmacovigilance Market Estimate by Deployment (USD MN)
  • Canada Pharmacovigilance Market Estimate by End User (USD MN)
  • Mexico Pharmacovigilance Market Analysis by Type (USD MN)
  • Mexico Pharmacovigilance Market Estimate by Deployment (USD MN)
  • Mexico Pharmacovigilance Market Estimate by End User (USD MN)
  • Europe Pharmacovigilance Market Analysis by Type (USD MN)
  • Europe Pharmacovigilance Market Estimate by Deployment (USD MN)
  • Europe Pharmacovigilance Market Analysis by End User (USD MN)
  • Europe Pharmacovigilance Market Estimate by Country (USD MN)
  • United Kingdom Pharmacovigilance Market Analysis by Type (USD MN)
  • United Kingdom Pharmacovigilance Market Estimate by Deployment (USD MN)
  • United Kingdom Pharmacovigilance Market Analysis by End User (USD MN)
  • France Pharmacovigilance Market Analysis by Type (USD MN)
  • France Pharmacovigilance Market Estimate by Deployment (USD MN)
  • France Pharmacovigilance Market Analysis by End User (USD MN)
  • Germany Pharmacovigilance Market Analysis by Type (USD MN)
  • Germany Pharmacovigilance Market Estimate by Deployment (USD MN)
  • Germany Pharmacovigilance Market Analysis by End User (USD MN)
  • Italy Pharmacovigilance Market Analysis by Type (USD MN)
  • Italy Pharmacovigilance Market Estimate by Deployment (USD MN)
  • Italy Pharmacovigilance Market Analysis by End User (USD MN)
  • Russia Pharmacovigilance Market Analysis by Type (USD MN)
  • Russia Pharmacovigilance Market Estimate by Deployment (USD MN)
  • Russia Pharmacovigilance Market Analysis by End User (USD MN)
  • Spain Pharmacovigilance Market Analysis by Type (USD MN)
  • Spain Pharmacovigilance Market Estimate by Deployment (USD MN)
  • Spain Pharmacovigilance Market Analysis by End User (USD MN)
  • Rest of Europe Pharmacovigilance Market Analysis by Type (USD MN)
  • Rest of Europe Pharmacovigilance Market Estimate by Deployment (USD MN)
  • Rest of Europe Pharmacovigilance Market Analysis by End User (USD MN)
  • Asia Pacific Pharmacovigilance Market Analysis by Type (USD MN)
  • Asia Pacific Pharmacovigilance Market Estimate by Deployment (USD MN)
  • Asia Pacific Pharmacovigilance Market Analysis by End User (USD MN)
  • Asia Pacific Pharmacovigilance Market Estimate by Country (USD MN)
  • China Pharmacovigilance Market Analysis by Type (USD MN)
  • China Pharmacovigilance Market Estimate by Deployment (USD MN)
  • China Pharmacovigilance Market Analysis by End User (USD MN)
  • Japan Pharmacovigilance Market Analysis by Type (USD MN)
  • Japan Pharmacovigilance Market Estimate by Deployment (USD MN)
  • Japan Pharmacovigilance Market Analysis by End User (USD MN)
  • India Pharmacovigilance Market Analysis by Type (USD MN)
  • India Pharmacovigilance Market Estimate by Deployment (USD MN)
  • India Pharmacovigilance Market Analysis by End User (USD MN)
  • South Korea Pharmacovigilance Market Analysis by Type (USD MN)
  • South Korea Pharmacovigilance Market Estimate by Deployment (USD MN)
  • South Korea Pharmacovigilance Market Analysis by End User (USD MN)
  • Australia Pharmacovigilance Market Analysis by Type (USD MN)
  • Australia Pharmacovigilance Market Estimate by Deployment (USD MN)
  • Australia Pharmacovigilance Market Analysis by End User (USD MN)
  • Rest of Asia Pacific Pharmacovigilance Market Analysis by Type (USD MN)
  • Rest of Asia Pacific Pharmacovigilance Market Estimate by Deployment (USD MN)
  • Rest of Asia Pacific Pharmacovigilance Market Analysis by End User (USD MN)
  • Latin America Pharmacovigilance Market Analysis by Type (USD MN)
  • Latin America Pharmacovigilance Market Estimate by Deployment (USD MN)
  • Latin America Pharmacovigilance Market Analysis by End User (USD MN)
  • Latin America Pharmacovigilance Market Estimate by Country (USD MN)
  • Brazil Pharmacovigilance Market Analysis by Type (USD MN)
  • Brazil Pharmacovigilance Market Estimate by Deployment (USD MN)
  • Brazil Pharmacovigilance Market Analysis by End User (USD MN)
  • Argentina Pharmacovigilance Market Analysis by Type (USD MN)
  • Argentina Pharmacovigilance Market Estimate by Deployment (USD MN)
  • Argentina Pharmacovigilance Market Analysis by End User (USD MN)
  • Peru Pharmacovigilance Market Analysis by Type (USD MN)
  • Peru Pharmacovigilance Market Estimate by Deployment (USD MN)
  • Peru Pharmacovigilance Market Analysis by End User (USD MN)
  • Chile Pharmacovigilance Market Analysis by Type (USD MN)
  • Chile Pharmacovigilance Market Estimate by Deployment (USD MN)
  • Chile Pharmacovigilance Market Analysis by End User (USD MN)
  • Rest of Latin America Pharmacovigilance Market Analysis by Type (USD MN)
  • Rest of Latin America Pharmacovigilance Market Estimate by Deployment (USD MN)
  • Rest of Latin America Pharmacovigilance Market Analysis by End User (USD MN)
  • Middle East & Africa Pharmacovigilance Market Analysis by Type (USD MN)
  • Middle East & Africa Pharmacovigilance Market Estimate by Deployment (USD MN)
  • Middle East & Africa Pharmacovigilance Market Analysis by End User (USD MN)
  • Middle East & Africa Pharmacovigilance Market Estimate by Country (USD MN)
  • Saudi Arabia Pharmacovigilance Market Analysis by Type (USD MN)
  • Saudi Arabia Pharmacovigilance Market Estimate by Deployment (USD MN)
  • Saudi Arabia Pharmacovigilance Market Analysis by End User (USD MN)
  • UAE Pharmacovigilance Market Analysis by Type (USD MN)
  • UAE Pharmacovigilance Market Estimate by Deployment (USD MN)
  • UAE Pharmacovigilance Market Analysis by End User (USD MN)
  • Israel Pharmacovigilance Market Analysis by Type (USD MN)
  • Israel Pharmacovigilance Market Estimate by Deployment (USD MN)
  • Israel Pharmacovigilance Market Analysis by End User (USD MN)
  • South Africa Pharmacovigilance Market Analysis by Type (USD MN)
  • South Africa Pharmacovigilance Market Estimate by Deployment (USD MN)
  • South Africa Pharmacovigilance Market Analysis by End User (USD MN)
  • Rest of Middle East and Africa Pharmacovigilance Market Analysis by Type (USD MN)
  • Rest of Middle East and Africa Pharmacovigilance Market Estimate by Deployment (USD MN)
  • Rest of Middle East and Africa Pharmacovigilance Market Analysis by End User (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
 
LIST OF FIGURES
 
  • Research Scope of Pharmacovigilance Report
  • Market Research Process
  • Market Research Methodology
  • Global Pharmacovigilance Market Size, by Region (2019)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Deployment
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Pharmacovigilance Market Analysis by Type
  • Global Pharmacovigilance Market Analysis in Service by Region
  • Global Pharmacovigilance Market Analysis in Software by Region
  • Global Pharmacovigilance Market Analysis by Deployment
  • Global Pharmacovigilance Market Analysis in In-house by Region
  • Global Pharmacovigilance Market Analysis in Outsource by Region
  • Global Pharmacovigilance Market Analysis by End User
  • Global Pharmacovigilance Market Analysis in Hospitals by Region
  • Global Pharmacovigilance Market Analysis in Pharmaceutical Companies by Region
  • Global Pharmacovigilance Market Analysis in Others by Region
  • Global Pharmacovigilance Market by Revenue
  • North America Pharmacovigilance Market by Revenue
  • Europe Pharmacovigilance Market by Revenue
  • Asia Pacific Pharmacovigilance Market by Revenue
  • Latin America Pharmacovigilance Market by Revenue
  • Middle East & Africa Pharmacovigilance Market by Revenue
  • Recent Development in Pharmacovigilance Industry
  • Company Market Share Analysis, 2019
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials